跳至主要内容
临床试验/IRCT20200106046023N1
IRCT20200106046023N1已完成2 期

Assessment of the botulinum toxin type A effect on Intensified Raynauds Phenomenon in Sclerodermic patients

Oroumia University of Medical Sciences0 个研究点目标入组 11 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
11

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients with scleroderma based on ACR criteria
  • Patients with Age over 18 years
  • Intensified and Resistant Raynauds

排除标准

  • A history of allergy to Botox
  • History of myasthenia gravis disease
  • Pregnancy and lactation
  • Taking estrogen-containing pills in the last month
  • History of vascular surgery and sympathectomy
  • Consumption of Aminoglycoside Antibiotics
  • The presence of active infection
  • The presence of severe bleeding tendency

研究者

发起方
Oroumia University of Medical Sciences

相似试验

Assessment of the botulinum toxin type A effect on... | 临床试验